All In Biotech

Drug Trial Radar · NCT07213973

Pharmacokinetics, Safety, and Efficacy of Povorcitinib in Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa

A Phase 2, Open-Label Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Povorcitinib in Adolescents With Moderate to Severe Hidradenitis Suppurativa

Last checked: Nov 20, 2026Latest source record: Nov 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

40

Planned (sponsor's estimate)

Start

Feb 2, 2026

Primary completion

Mar 25, 2028

Study completion Mar 25, 2028

Sponsor

Lead sponsor
Incyte CorporationIncyte (INCY)
Sponsor type
Industry
First posted
Oct 9, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the pharmacokinetics, safety, and efficacy of povorcitinib in adolescent participants with moderate to severe hidradenitis suppurativa over a 54-week open-label treatment period.

Conditions

  • Hidradenitis Suppurativa (HS)

Interventions

  • PovorcitinibDrug

    Oral; Tablet

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of participants with Treatment-Emergent Adverse Events (TEAEs)Time frame: Baseline through Week 54
  2. Apparent clearanceTime frame: Up to Week 24
  3. Apparent volume of distributionTime frame: Up to Week 24
  4. Apparent oral absorption rate constantTime frame: Up to Week 24
  5. Absorption lag timeTime frame: Up to Week 24
  6. Maximum plasma drug concentration at steady stateTime frame: Up to Week 24
  7. Average plasma drug concentration at steady stateTime frame: Up to Week 24
  8. Plasma concentration at steady state for the dosing intervalTime frame: Up to Week 24
  9. Time to maximum plasma concentration at steady stateTime frame: Up to Week 24
  10. Terminal half-lifeTime frame: Up to Week 24

Locations

28 sites in 2 countries. Site status is shown where the registry gives one.

  • University of Alabama At Birmingham

    Birmingham, Alabama · Recruiting

  • Medical Dermatology Specialists Phoenix

    Phoenix, Arizona · Recruiting

  • Saguaro Dermatology

    Phoenix, Arizona · Recruiting

  • Uconn Health

    Farmington, Connecticut · Recruiting

  • University of Miami Miller School of Medicine

    Miami, Florida · Recruiting

  • Skin Research of South Florida, Llc

    Miami, Florida · Recruiting

  • Trueblue Clinical Research

    Tampa, Florida · Recruiting

  • Advanced Medical Research Pc

    Sandy Springs, Georgia · Recruiting

  • Endeavor Health Medical Group

    Skokie, Illinois · Recruiting

  • Dermatology Skin Cancer Center Leawood

    Leawood, Kansas · Recruiting

  • Equity Medical

    Bowling Green, Kentucky · Recruiting

  • Johns Hopkins Univ Schl of Medicine

    Baltimore, Maryland · Recruiting

  • Boston Childrens Hospital

    Boston, Massachusetts · Recruiting

  • Oakland Hills Dermatology Pc

    Auburn Hills, Michigan · Recruiting

  • Wayne State University Physician Group Dermatology

    Detroit, Michigan · Recruiting

  • Revival Research Institute, Llc Troy

    Troy, Michigan · Recruiting

  • Washington University

    St Louis, Missouri · Recruiting

  • Boeson Research Missoula 2825 Fort Missoula Rd

    Missoula, Montana · Recruiting

  • University of New Mexico Hospital

    Albuquerque, New Mexico · Recruiting

  • Geisinger Medical Center

    Danville, Pennsylvania · Recruiting

  • Bellaire Dermatology Associates Bda

    Bellaire, Texas · Recruiting

  • Texas Dermatology Research Center

    Dallas, Texas · Recruiting

  • 3A Research Llc West Location

    El Paso, Texas · Recruiting

  • Jordan Valley Dermatology Center

    South Jordan, Utah · Recruiting

  • Skincare Studio Dermatology Centre

    St. John's, Canada · Recruiting

  • Dermcare Clinic

    Mississauga, Ontario, Canada · Recruiting

  • York Dermatology Center

    Richmond Hill, Ontario, Canada · Recruiting

  • The Hospital For Sick Children

    Toronto, Ontario, Canada · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.